Primary Cells Market Is Expected to Reach Register USD 1,233.67 Million at a CAGR of 8.13% By 2025

Primary Cells Market Is Expected to Reach Register USD 1,233.67 Million at a CAGR of 8.13% By 2025

Primary Cells Market
Primary Cells Market: Information by Source (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, and Skeletal and Muscle Cells) Type (Human Primary Cells and Animal Primary Cells), End User (Pharmaceutical and Biotechnology Companies and Research Institutes) and Region – Forecast till 2025

Market Highlights

Primary Cells Market is expected to register a CAGR of 8.13% during the forecast period, with a market value of USD 1,233.67 Million till 2025. Primary human cells are isolated directly from normal human tissue or blood cells via the enzymatic or mechanical method. Primary cells retain their fundamental cellular functions. Hence, their use in cell-based research programs is increasing significantly.

Numerous factors such as rapid growth in the biotechnology and biopharmaceutical industries, growing cancer research, rising adoption of primary cells over cell lines, increasing demand for monoclonal antibodies, and rising healthcare expenditure are anticipated to drive the growth of the market during the forecast period. Additionally, the growing research on personalized therapies and stem cells is likely to contribute to market growth. However, the high cost of advanced primary cells and risk of contamination may hamper the growth of the market. The increasing preference of primary cells in research and development to develop new drug acts as opportunities for the growth of the primary cells market.

Request Free Sample Copy at:

Segment Analysis

The Global Primary Cells Market is segmented into Source, Type, and End User. By source, the market has been segmented into hematopoietic cells, skin cells, gastrointestinal cells, liver cells, lung cells, and skeletal and muscle cells.

Based on type, the market has been segmented into human primary cells and animal primary cells. Based on end user, the market has been segmented into pharmaceutical and biotechnology companies and research institutes.

Regional Analysis

The Global Primary Cells Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global primary cells market. This is owing to the increasing prevalence of cancer and growing government funding in research. Also, the key players in the market are engaged in new launches and strategic collaborations to hold their market position. For instance, in January 2017, STEMCELL Technologies Inc. entered into a license agreement with Cincinnati Children’s Hospital Medical Center, to commercialize the center’s technology for producing gastrointestinal organoids from pluripotent stem cells (PSCs). Thus, all these factors are driving the primary cells market.

The European market holds the second-largest position in the global primary cells market. Factors attributing to the growth of the market include the rising prevalence of lifestyle-associated conditions, and the presence of developed economies such as Germany, the UK, and France boosts the market growth.

Asia-Pacific is estimated to be the fastest-growing region owing to the rising prevalence of chronic and acute diseases such as HIV, cancer, and diabetes, and the development of new infrastructure to support the healthcare industry are expected to drive the market growth.

The primary cells market in the Middle East & Africa is expected to grow at a significant rate owing to the implementation of a new business strategy such as a growing distribution channel, product launch in the untapped market by the healthcare companies increases the market growth in this region.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Primary Cells Market—Thermo Fisher Scientific Inc. (US), AllCells (US), American Type Culture Collection (ATCC) (Virginia), Axol Bioscience Ltd (UK), Cell Biologics, Inc. (Chicago), Lonza Group, AG (Switzerland), Merck KGaA (Germany), PromoCell (UK), STEMCELL Technologies Inc. (Canada), ZenBio, Inc. (Research Triangle Park, NC), and among others.  

Key Findings of the Study

The Global Primary Cells Market was valued at USD 722.61 Million in 2018, is estimated to grow at USD 1,233.67 Million by 2025 at a CAGR of 8.13% during the assessment period

Asia-Pacific accounted for the largest share of the global market due to the increasing per capita health spending, growing geriatric population base, and developing countries enhance the market growth

Based on source, the hematopoietic cells segment accounted for the largest market share in 2018

Check Discount at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India